MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
Funding: U.S. Federal
*Funding: HHS
*HHS: Contracts, Contractors & Awards
*BARDA: Contracts (IDIQ, GWACS, Etc.), Contractors & Awardees
*Contractors & Awardees: BARDA
Moderna, Inc. (NASDAQ:MRNA)*
Finance & Acquisitions: Moderna
Parents
Moderna, Inc. (NASDAQ:MRNA)*
Children
2014: Moderna Spins Out mRNA Cancer Drugs Into New Company, Onkaido (2014)
2014: Moderna, Living a Charmed Life, Pulls in Another $125M From Alexion (2014)
2018: Existing investors that also participated in this round include Fidelity Management and Research, Pictet, Viking Global Investors, ArrowMark Partners and Alexandria Venture Investments.
2018: Moderna boosts unicorn status with a whopping $500M raise and $7B valuation – Endpoints News
2018: Moderna raised the cash from a broad, global syndicate that stretched from the Middle East to Europe and on to China.
2018: The group included the Abu Dhabi Investment Authority, BB Biotech AG, Julius Baer, Singapore-based EDBI and Sequoia Capital China.
2018: UPDATED: Moderna skirts the reefs of disaster and sails into Wall Street with a $604M IPO bounty
2020: After nearly $1B in research funding, Moderna takes $1.5B coronavirus vaccine order from U.S.
2020: Moderna executives sell stock as coronavirus vaccine boosts company shares
2020: Moderna lands $100M upfront in deals with Vertex, Chiesi
2020: Moderna Launches Phase III COVID-19 Vaccine Trial with $472 Million More in BARDA Funding
2022: Moderna, Inc. 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
2023: Moderna snaps up Japan's OriCiro Genomics in mRNA manufacturing push
2023: Moderna's globetrotting BD team snags an mRNA upstart with some handy new tech tools
2024: Moderna, Inc. 2024 Q4 - Results - Earnings Call Presentation
2025: Moderna, Inc. 2024 Q4 - Results - Earnings Call Presentation
2025: Trump administration cancels $766 million Moderna contract to fight pandemic flu
2026: Moderna settles Covid vaccine patent suit for up to $2.25 billion
Moderna, which only emerged from stealth mode in 2012, has raked in an incredible $415 million in private equity investment, government support, and partnership dollars from AstraZeneca.
OriCiro Genomics
Revenue (2018): $135 million
Revenue (2019): $60 million
Jumps
*Key People: Moderna
Organization & Developments: Moderna